These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9741868)

  • 1. Guidelines for quality assurance in multicenter trials: a position paper.
    Knatterud GL; Rockhold FW; George SL; Barton FB; Davis CE; Fairweather WR; Honohan T; Mowery R; O'Neill R
    Control Clin Trials; 1998 Oct; 19(5):477-93. PubMed ID: 9741868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial monitoring: hit or miss?
    Cohen J
    Science; 1994 Jun; 264(5165):1534-7. PubMed ID: 8202707
    [No Abstract]   [Full Text] [Related]  

  • 3. NCI audit of NSABP continues, NSABP reorganizing structure.
    J Natl Cancer Inst; 1994 Jun; 86(11):822-4. PubMed ID: 8182761
    [No Abstract]   [Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implications of surgical quality assurance in cancer clinical trials.
    Haase GM
    Cancer; 1994 Nov; 74(9 Suppl):2630-7. PubMed ID: 7954277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.
    Bekelman JE; Deye JA; Vikram B; Bentzen SM; Bruner D; Curran WJ; Dignam J; Efstathiou JA; FitzGerald TJ; Hurkmans C; Ibbott GS; Lee JJ; Merchant TE; Michalski J; Palta JR; Simon R; Ten Haken RK; Timmerman R; Tunis S; Coleman CN; Purdy J
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):782-90. PubMed ID: 22425219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infrastructure of cancer clinical trial cooperative groups in western countries].
    Fukuda H
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality issues in clinical research and the implications on health policy (QICRHP).
    Njie VP; Thomas AC
    J Prof Nurs; 2001; 17(5):233-42. PubMed ID: 11559879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologic Oncology Group quality assurance audits: analysis and initiatives for improvement.
    Blessing JA; Bialy SA; Whitney CW; Stonebraker BL; Stehman FB
    Clin Trials; 2010 Aug; 7(4):390-9. PubMed ID: 20576671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assurance for interventions in clinical trials. Multicenter data monitoring, data management, and analysis.
    Pollock BH
    Cancer; 1994 Nov; 74(9 Suppl):2647-52. PubMed ID: 7954280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved quality monitoring of multi-center acupuncture clinical trials in China.
    Zhao L; Liang FR; Li Y; Zhang FW; Zheng H; Wu X
    Trials; 2009 Dec; 10():123. PubMed ID: 20035630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veto -- or threat thereof -- prevails over majority as 102nd Congress adjourns.
    Wash Memo Alan Guttmacher Inst; 1992 Oct; (15):2-4. PubMed ID: 12317790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B.
    Weiss RB; Vogelzang NJ; Peterson BA; Panasci LC; Carpenter JT; Gavigan M; Sartell K; Frei E; McIntyre OR
    JAMA; 1993 Jul; 270(4):459-64. PubMed ID: 8320783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of monitoring practices in cancer clinical trials.
    George SL
    Stat Med; 1993 Mar; 12(5-6):435-50. PubMed ID: 8493422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCI trial hearing elicits vow of more oversight.
    Marwick C
    JAMA; 1994 May; 271(18):1391. PubMed ID: 8176788
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of data audits in detecting scientific misconduct. Results of the FDA program.
    Shapiro MF; Charrow RP
    JAMA; 1989 May; 261(17):2505-11. PubMed ID: 2704109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing data quality and the variability of source data verification auditing methods in clinical research settings.
    Houston L; Probst Y; Martin A
    J Biomed Inform; 2018 Jul; 83():25-32. PubMed ID: 29783038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ; McKinney MM; Carpenter WR
    Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
    Soran A; Nesbitt L; Mamounas EP; Lembersky B; Bryant J; Anderson S; Brown A; Passarello M
    Clin Trials; 2006; 3(5):478-85. PubMed ID: 17060221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.